Edgewise Therapeutics, Inc. (EWTX)

NASDAQ

$23.95

+$0.33 (1.40%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$23.01$24.31

Open $23.67

52 Week Range

$10.60$35.50

Previous Close $23.62

Market Cap2.54B

Volume1.78M

Avg Volume1.07M

P/E (TTM)-16.68

EPS (TTM)$-1.44

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$20.00

Based on 2 analysts (last year)

High Target

$20.00

Low Target

$20.00

Potential downside of -16.49%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$20.00

1 analysts

Last Year

$35.00

2 analysts

All Time

$43.29

7 analysts

Analyst Consensus

Current Consensus

Buy

Based on 9 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C+

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows3/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 24, 2025	Unknown	Goldman Sachs	$20.00	$16.59	+20.55%
Mar 7, 2025	Unknown	Scotiabank	$50.00	$28.01	+78.51%
Dec 5, 2024	Srikripa Devarakonda	Truist Financial	$50.00	$31.57	+58.38%
Oct 11, 2024	Yasmeen Rahimi	Piper Sandler	$51.00	$30.45

Recent Analyst Actions


Nov 14, 2025	Maintained	JP Morgan	Overweight	Overweight
Nov 7, 2025	Maintained	Wedbush	Outperform	Outperform
Nov 7, 2025	Maintained	RBC Capital	Outperform	Outperform
Aug 19, 2025	Maintained	JP Morgan	Overweight	Overweight
Aug 8, 2025	Maintained	RBC Capital	Outperform	Outperform

Showing 1 to 5 of 64 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$20.00

Based on 2 analysts (last year)

High Target

$20.00

Low Target

$20.00

Potential downside of -16.49%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$20.00

1 analysts

Last Year

$35.00

2 analysts

All Time

$43.29

7 analysts

Analyst Consensus

Current Consensus

Buy

Based on 9 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

C+

(Score: 2)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows3/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share3/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 24, 2025	Unknown	Goldman Sachs	$20.00	$16.59	+20.55%
Mar 7, 2025	Unknown	Scotiabank	$50.00	$28.01	+78.51%
Dec 5, 2024	Srikripa Devarakonda	Truist Financial	$50.00	$31.57	+58.38%
Oct 11, 2024	Yasmeen Rahimi	Piper Sandler	$51.00	$30.45

Recent Analyst Actions


Nov 14, 2025	Maintained	JP Morgan	Overweight	Overweight
Nov 7, 2025	Maintained	Wedbush	Outperform	Outperform
Nov 7, 2025	Maintained	RBC Capital	Outperform	Outperform
Aug 19, 2025	Maintained	JP Morgan	Overweight	Overweight
Aug 8, 2025	Maintained	RBC Capital	Outperform	Outperform

Showing 1 to 5 of 64 entries